TrialCard CEO David Cunningham Named to PharmaVOICE 100

Cary, NC (PRWEB) August 01, 2014

TrialCard, an industry leader in patient access solutions for pharmaceutical brands, is pleased to announce that David Cunningham, founder and CEO, has been named to the 2014 PharmaVOICE “100 Most Inspiring People.” An annual recognition in the publication’s July/August edition, the PharmaVOICE 100 is an award based on nominees' ability to inspire and motivate. David was selected from nominations submitted by industry peers.

"Dave Cunningham, CEO and cofounder of TrialCard, is noted for being an entrepreneur, an inspirational leader, and an innovator as he continues to cultivate new cutting-edge solutions to increase patient-care access," lauded Taren Grom, co-founder and editor of PharmaVOICE. "We are pleased to share his unique story with our readers. His impact on opening up new avenues for patients, especially those for specialty and rare disease drugs, through the launch of innovative solutions, is inspiring."

As a co-founder of TrialCard, David early on established a team culture driven by innovation and leadership. PharmaVOICE quoted David: “We empower our people and allow our people to make hard decisions. Our team is told to think and do, not to be told what to do.” Now, TrialCard is thriving, taking the foundation of the business and expanding patient access into other areas such as advanced analytics, hub programs, pharmacy services, and more.

“I am honored to be selected for the 2014 PharmaVOICE 100 list” David acknowledged. “I am fortunate to be part of such a talented and innovative team at TrialCard.”

The entire team at TrialCard congratulates David on being named to PharmaVOICE 100 for 2014.

About TrialCard, Inc.
TrialCard Incorporated provides a comprehensive portfolio of solutions in Customer Experience Management, Patient Access Resources, Pharmacy Services, Pulse Analytics, and Reimbursement Support Hub Resources for the life cycle of pharmaceutical brands. Since opening its doors in 2001, TrialCard has been awarded nine patents related to the processing and marketing of patient access programs. TrialCard is the largest provider of patient access programs in the industry, processing over $1 billion in patient benefits per year to help brand manufacturers achieve their goals with prescribers, patients, and pharmacists.
For more information on TrialCard, please visit http://www.trialcard.com.

About PharmaVOICE.com
PharmaVOICE.com is a Website for life-sciences executives and other healthcare-service related professionals. PharmaVOICE.com is produced by PharmaLinx LLC, publishers of PharmaVOICE magazine and the VIEWs.
The primary audience is made up of executive and corporate management from pharmaceutical, biotechnology, drug delivery, marketing communications, clinical services, contract research, drug development, and information technology companies, as well as other industry sectors. Additionally, PharmaVOICE.com has readers from around the world.

PharmaVOICE.com provides access to all of the articles that have appeared in the print publications of PharmaVOICE and the VIEWs. PharmaVOICE.com also provides an online calendar of industry events, an online discussion forum, a monthly interactive opinion poll, and other online content, supported by a robust search engine.

Contact:
Michael Harris
mharris(at)trialcard(dot)com
6501 Weston Parkway, Suite 370
Cary, NC 27513
Direct: 919-415-3270

PDF Print